BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 8, 2017
View Archived Issues
Lung Therapeutics completes series B financing
Read More
Mustang Bio enters CAR T therapy agreement with City of Hope
Read More
Roivant Sciences launches new company
Read More
Novartis discovers novel MALT1 inhibitors
Read More
New MAPK 1 inhibtors patented by AstraZeneca
Read More
Neuform Pharmaceuticals divulges new PI3Kdelta inhibitors
Read More
Actelion identifies prostanoid EP2/EP4 receptor antagonists
Read More
Bristol-Myers Squibb patents TYK2 inhibitors
Read More
Merck & Co. discloses novel HIV integrase inhibitors
Read More
Mateon Therapeutics' OXi-4503 awarded FDA fast track designation
Read More
Synlogic completes first phase of collaboration with AbbVie
Read More
Teva reports results from second phase III HALO study of fremanezumab
Read More
First patient dosed in phase I/II study of ARQ-092
Read More
InCarda Therapeutics announces topline data from phase I study of InRhythm
Read More
Avanir Pharmaceuticals begins enrolling patients in phase II study of AVP-786
Read More
BlackThorn and Mindstrong Health enter biomarker collaboration
Read More
FDA gives fast track designation to Calithera Biosciences' CB-839
Read More
ADMA completes acquisition of Biotest Pharmaceuticals' therapy business unit
Read More
First data for the antibody-drug conjugate ABBV-221 in solid tumors
Read More
Novel M. tuberculosis dihydrofolate reductase inhibitor identified for in vivo testing
Read More
Shire to transfer IND for phase II/III study of alpha-1 antitrypsin i.v. to Kamada
Read More
Caris and Foundation Medicine announce collaborations with NCI and ECOG-ACRIN
Read More
Lilly presents detailed results from MONARCH2 trial of abemaciclib in advanced breast cancer
Read More
Cellceutix changes its name to Innovation Pharmaceuticals
Read More
First clinical data for AGEN-1884 in advanced solid malignancies
Read More
Actelion gives an update on the phase III IMPACT program
Read More
Tiziana Life Sciences discontinues its Bcl-3 preclinical development program
Read More
APHINITY trial: pertuzumab plus herceptin in early adjuvant breast cancer
Read More
Symproic tablets launched in Japan for the treatment of opioid-induced constipation
Read More
